California 2023-2024 Regular Session

California Assembly Bill AB1926

Introduced
1/25/24  
Introduced
1/25/24  
Refer
2/5/24  
Refer
2/5/24  
Report Pass
3/19/24  
Report Pass
3/19/24  
Refer
3/20/24  
Refer
3/20/24  
Report Pass
4/3/24  
Report Pass
4/3/24  
Refer
4/3/24  
Refer
4/3/24  
Refer
4/17/24  
Refer
4/17/24  
Report Pass
5/16/24  
Report Pass
5/16/24  
Engrossed
5/21/24  
Engrossed
5/21/24  
Refer
5/22/24  
Refer
5/22/24  
Refer
5/29/24  
Refer
5/29/24  
Report Pass
6/13/24  
Report Pass
6/13/24  
Refer
6/13/24  
Refer
6/13/24  
Refer
6/24/24  

Caption

Health care coverage: regional enteritis.

Impact

The bill's implementation will have significant implications for state healthcare regulations as it introduces new coverage mandates that health insurers must comply with. By requiring coverage for dietary enteral formulas, AB 1926 is expected to alleviate some of the financial burdens faced by families dealing with chronic digestive issues. However, Medi-Cal managed care plans are exempt from this requirement if such services are excluded from their contracts, which may leave some patients without the necessary support.

Summary

Assembly Bill 1926, introduced by Assembly Member Connolly, aims to expand healthcare coverage for patients suffering from chronic digestive diseases and inherited metabolic disorders. Set to go into effect on July 1, 2025, the bill mandates that all health care service plans and disability insurance policies provide coverage for dietary enteral formulas that are deemed medically necessary for these conditions. This change is intended to ensure that those with conditions like Crohn's disease receive adequate nutritional support, which is crucial for their treatment and overall health.

Sentiment

The sentiment around AB 1926 appears generally positive among advocates for health reform, particularly those representing patients with chronic digestive diseases. Proponents argue that this legislation is a critical step towards ensuring equitable healthcare access for all Californians suffering from these serious health issues. However, some skepticism exists regarding the bill's potential impacts, particularly concerning its implications for Medi-Cal recipients and the overall burden on insurance providers to comply with expanded coverage mandates.

Contention

Notable points of contention within the discussions surrounding AB 1926 include concerns about the financial impact on insurance providers and the feasibility of such mandates. Critics argue that adding coverage for dietary enteral formulas could lead to increased premiums or additional costs for consumers. Moreover, the exemption for Medi-Cal managed care plans raises questions about equity in healthcare access, potentially leaving vulnerable populations without necessary dietary supports mandated by the bill.

Companion Bills

No companion bills found.

Previously Filed As

CA AB620

Health care coverage for metabolic disorders.

CA AB2516

Health care coverage: human papillomavirus.

CA AB350

Health care coverage: fluoride treatments.

CA SB1438

Health insurance coverage; insulin

CA HB2243

Insulin; health insurance coverage

CA SB1216

Health insurance coverage; insulin

CA SB62

Health care coverage: essential health benefits.

CA AB224

Health care coverage: essential health benefits.

CA AB1240

Health care coverage: essential health benefits.

CA SB1473

Health care coverage.

Similar Bills

CA AB620

Health care coverage for metabolic disorders.

CA AB1622

Family physicians.

CA SB306

Sexually transmitted disease: testing.

CA AB1450

California Children’s Services Program: providers.

CA AB2294

Workers’ compensation.

CA AB399

The Medical Provider Network Transparency Act of 2022.

CA SB636

Workers’ compensation: utilization review.